Department of Medicine, University of Washington, Seattle, WA 98104, USA.
AIDS. 2012 Nov 13;26(17):2155-63. doi: 10.1097/QAD.0b013e328359b99b.
Cervicovaginal HIV-1-neutralizing immunoglobulin A (IgA) was associated with reduced HIV-1 acquisition in a cohort of commercial sex workers. We aimed to define the prevalence and correlates of HIV-1-neutralizing IgA from HIV-1-exposed seronegative (HESN) women in HIV-1-serodiscordant relationships.
HIV-1-serodiscordant couples in Nairobi were enrolled and followed quarterly up to 2 years, and women in concordant HIV-1-negative relationships were enrolled as controls. Cervicovaginal, seminal, and blood samples were collected at enrollment and follow-up. Cervicovaginal IgA was assessed for HIV-1-neutralizing activity by a peripheral blood mononuclear cell-based assay using an HIV-1 clade A primary isolate.
HESN women in discordant relationships had significantly more HIV-1-neutralizing IgA detected in genital secretions compared with control women [36 of 155 (23%) vs. four of 70 (6%), respectively; odds ratio (OR) 5.0; 95% confidence interval (CI) 1.70-14.64; P = 0.003]. These responses persisted over time in all available follow-up cervicovaginal samples from women with detectable HIV-1-neutralizing IgA at baseline. Partner median HIV-1 plasma viral load was lower among women who had HIV-1-neutralizing IgA compared with women without detectable activity (4.3 vs. 4.8 log(10) copies/ml, respectively; OR 0.70; 95% CI 0.51-0.94; P = 0.02). A similar trend was found with partner seminal viral load (OR 0.57; 95% CI 0.32-1.02; P = 0.06).
HESN women were five times more likely to have neutralizing IgA in cervicovaginal secretions than low-risk control women, and these responses were inversely associated with partner viral load. These observations support the existence of antiviral activity in the mucosal IgA fraction following sexual HIV-1 exposure.
在商业性工作者队列中,宫颈阴道 HIV-1 中和性免疫球蛋白 A(IgA)与 HIV-1 感染减少相关。本研究旨在确定 HIV-1 血清学不一致(serodiscordant)伴侣中 HIV-1 暴露但血清阴性(HIV-1-exposed seronegative,HESN)女性的 HIV-1 中和性 IgA 的流行率及其相关因素。
在肯尼亚,招募了 HIV-1 血清学不一致的夫妇,并每季度随访至 2 年,同时招募 HIV-1 阴性一致性伴侣中的女性作为对照。在入组和随访时采集宫颈阴道、精液和血液样本。使用基于外周血单核细胞的测定法,使用 HIV-1 群 A 原发性分离物评估宫颈阴道 IgA 的 HIV-1 中和活性。
与对照组女性(分别为 36 例[23%]和 4 例[6%])相比,HIV-1 血清学不一致伴侣中的 HESN 女性的生殖道分泌物中 HIV-1 中和性 IgA 明显更多[155 例中的 36 例(23%);比值比(odds ratio,OR)5.0;95%置信区间(confidence interval,CI)1.70-14.64;P = 0.003]。在所有可获得的基线时可检测到 HIV-1 中和性 IgA 的女性的后续宫颈阴道样本中,这些反应随时间推移而持续存在。与未检测到中和活性的女性相比,具有 HIV-1 中和性 IgA 的女性的伴侣 HIV-1 血浆病毒载量较低(分别为 4.3 和 4.8 log10 拷贝/ml;OR 0.70;95%CI 0.51-0.94;P = 0.02)。在伴侣精液病毒载量中也发现了类似的趋势(OR 0.57;95%CI 0.32-1.02;P = 0.06)。
与低风险对照女性相比,HIV-1 暴露但血清阴性的女性生殖道分泌物中中和性 IgA 的可能性高 5 倍,且这些反应与伴侣病毒载量呈负相关。这些观察结果支持在性接触 HIV-1 暴露后,黏膜 IgA 部分存在抗病毒活性。